Cantor Equity (CEPO) news
Recent news
Cantor Equity Partners II Inc: Citigroup cuts to neutral from buy; raises target price to $14 from $10
Citigroup has revised its stance on Cantor Equity Partners II Inc, downgrading the stock from "buy" to "neutral" while simultaneously raising its target price to $14 from $10. This adjustment reflects a recalibration of expectations based on recent market dynamics and company performance. The move…
AInvest Wire · 1d agoCantor Equity Partners II Inc: Stonex raises target price to $18 from $12
Cantor Equity Partners II Inc has raised its target price for Stonex Group Inc (SNX) to $18 from $12, reflecting a more optimistic outlook on the company’s financial performance and market positioning [1]. The adjustment follows a recent analysis of Stonex’s operational metrics and industry trends,…
AInvest Wire · 2d agoSrx Global - To buy all outstanding stock of Cero Therapeutics, - SEC filing
SRX Global Inc. (NYSE American: SRXH) has announced its acquisition of senior secured debt in CERo Therapeutics Holdings, Inc. (OTCQB: CERO), an immunotherapy company focused on engineered T cell therapeutics for cancer treatment. This investment is intended to provide CERo with additional capital…
AInvest Wire · 7d agoCantor Equity Partners I - BSTR Holdings to pay Cepo $15 mln in cash due Sept 19 and Dec 1, 2026 - SEC filing
AInvest Wire · Aug 20, 2026Cantor Equity Partners I - board will not call meeting for BSTR deal; to seek alternative target - SEC filing
AInvest Wire · Aug 20, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.